These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38658552)

  • 1. High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue.
    Zhang N; Harbers L; Simonetti M; Diekmann C; Verron Q; Berrino E; Bellomo SE; Longo GMC; Ratz M; Schultz N; Tarish F; Su P; Han B; Wang W; Onorato S; Grassini D; Ballarino R; Giordano S; Yang Q; Sapino A; Frisén J; Alkass K; Druid H; Roukos V; Helleday T; Marchiò C; Bienko M; Crosetto N
    Nat Commun; 2024 Apr; 15(1):3475. PubMed ID: 38658552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
    Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
    BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue.
    Deitch AD; Miller GJ; deVere White RW
    Cancer; 1993 Sep; 72(5):1692-700. PubMed ID: 7688657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
    Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy measured on archived pretreatment biopsy material may correlate with prostate-specific antigen recurrence after prostate brachytherapy.
    Keyes M; Macaulay C; Hayes M; Korbelik J; Morris WJ; Palcic B
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):829-34. PubMed ID: 23688814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA ploidy in carcinoma of prostate.
    Dejter SW; Cunningham RE; Noguchi PD; Jones RV; Moul JW; McLeod DG; Lynch JH
    Urology; 1989 May; 33(5):361-6. PubMed ID: 2711553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatially resolved clonal copy number alterations in benign and malignant tissue.
    Erickson A; He M; Berglund E; Marklund M; Mirzazadeh R; Schultz N; Kvastad L; Andersson A; Bergenstråhle L; Bergenstråhle J; Larsson L; Alonso Galicia L; Shamikh A; Basmaci E; Díaz De Ståhl T; Rajakumar T; Doultsinos D; Thrane K; Ji AL; Khavari PA; Tarish F; Tanoglidi A; Maaskola J; Colling R; Mirtti T; Hamdy FC; Woodcock DJ; Helleday T; Mills IG; Lamb AD; Lundeberg J
    Nature; 2022 Aug; 608(7922):360-367. PubMed ID: 35948708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
    Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM
    Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
    Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
    Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection toward diploid cells in prostatic carcinoma derived cell cultures.
    Ketter R; Zwergel T; Romanakis K; Unteregger G; Ziegler M; Zang KD; Wullich B
    Prostate; 1996 Jun; 28(6):364-71. PubMed ID: 8650073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
    Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S
    Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer.
    Heidenreich B; Heidenreich A; Sesterhenn A; Srivastava S; Moul JW; Sesterhenn IA
    Eur Urol; 2000 Oct; 38(4):475-82. PubMed ID: 11025389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The landscape of somatic chromosomal copy number aberrations in GEM models of prostate carcinoma.
    Bianchi-Frias D; Hernandez SA; Coleman R; Wu H; Nelson PS
    Mol Cancer Res; 2015 Feb; 13(2):339-47. PubMed ID: 25298407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.
    Camacho N; Van Loo P; Edwards S; Kay JD; Matthews L; Haase K; Clark J; Dennis N; Thomas S; Kremeyer B; Zamora J; Butler AP; Gundem G; Merson S; Luxton H; Hawkins S; Ghori M; Marsden L; Lambert A; Karaszi K; Pelvender G; Massie CE; Kote-Jarai Z; Raine K; Jones D; Howat WJ; Hazell S; Livni N; Fisher C; Ogden C; Kumar P; Thompson A; Nicol D; Mayer E; Dudderidge T; Yu Y; Zhang H; Shah NC; Gnanapragasam VJ; ; Isaacs W; Visakorpi T; Hamdy F; Berney D; Verrill C; Warren AY; Wedge DC; Lynch AG; Foster CS; Lu YJ; Bova GS; Whitaker HC; McDermott U; Neal DE; Eeles R; Cooper CS; Brewer DS
    PLoS Genet; 2017 Sep; 13(9):e1007001. PubMed ID: 28945760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
    Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
    Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of DNA-ploidy and S-phase fraction in node-positive (stage D1) prostate cancer treated with androgen ablation.
    Pollack A; Troncoso P; Zagars GK; von Eschenbach AC; Mak AC; Wu CS; Terry NH
    Prostate; 1997 Apr; 31(1):21-8. PubMed ID: 9108882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer.
    Menon R; Deng M; Rüenauver K; Queisser A; Peifer M; Pfeifer M; Offermann A; Boehm D; Vogel W; Scheble V; Fend F; Kristiansen G; Wernert N; Oberbeckmann N; Biskup S; Rubin MA; Adler D; Perner S
    J Pathol; 2013 Dec; 231(4):505-16. PubMed ID: 24114522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of EpCAM
    Liu M; Di J; Liu Y; Su Z; Jiang B; Wang Z; Su X
    Cancer Biol Ther; 2018; 19(10):939-947. PubMed ID: 29580161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumor.
    Rozenblum E; Sotelo-Silveira JR; Kim GY; Zhu JY; Lau CC; McNeil N; Korolevich S; Liao H; Cherry JM; Munroe DJ; Ried T; Meltzer PS; Kuehl WM; Roschke AV
    PLoS One; 2017; 12(8):e0182610. PubMed ID: 28787462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.